Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches
Hepatitis C virus (HCV) infection causes viral hepatitis leading to hepatocellular carcinoma. Despite the clinical use of direct-acting antivirals (DAAs) still there is treatment failure in 5–10% cases. Therefore, it is crucial to develop new antivirals against HCV. In this endeavor, we developed th...
Main Authors: | Kamboj, S. (Author), Kumar, M. (Author), Rajput, A. (Author), Rastogi, A. (Author), Thakur, A. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Hepatitis C Viral Replication Complex
by: Hui-Chun Li, et al.
Published: (2021-03-01) -
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
by: Sulejmani N, et al.
Published: (2018-05-01) -
Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort
by: Ruben Brandão, et al.
Published: (2018-04-01) -
Investigating the modulation of viral translation by the Hepatitis C virus nonstructural protein 5A
Published: (2015) -
Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms
by: Elena Knops, et al.
Published: (2018-07-01)